OMF Introduces #OMFScienceWednesday

Introducing #OMFScienceWednesday! Every Wednesday, our Research Liaison Raeka Aiyar from Stanford University will post on Facebook about the science that OMF is supporting: background on key areas, updates on the latest research, explanations of topics relevant to ME/CFS… be sure to like our Facebook page so you don’t miss out!
To start with, what do we mean when we say ME/CFS is a molecular disease, and why is that helpful for research? Molecular biology involves DNA, RNA, metabolites, proteins, cytokines – and there is evidence that so many of these are involved in ME/CFS. Molecular biology presents new opportunities to study ME/CFS: this is the golden era of molecular technologies, like genomics and other ‘omics’ (transcriptomics, metabolomics, proteomics) that allow us to measure the full set of these molecules produced by the body, cheaply and effectively. These studies can help us to understand how the disease works – for example, which viruses may trigger it or whether genetics may increase your risk – and to identify molecular biomarkers that are clearly different in patients compared to healthy people, which may be useful in diagnosing ME/CFS. Finally, molecular biology will hopefully lead to new molecular treatments: knowing which molecules are out of balance could point to ways to treat ME/CFS.

A great example of this is the recent metabolomics study published by Dr. Bob Naviaux (http://www.pnas.org/content/113/37/E5472.long), in which he found several metabolites whose levels are different in ME/CFS patients. This metabolic ‘signature’ could be useful as a biomarker, and could help to understand the energy deficiency issues in the disease. OMF is supporting a metabolomics validation study to confirm and extend Dr. Naviaux’s findings, and a collaboration with Dr. Ron Davis’ group to use genome sequencing to understand how genetics may be influencing metabolism in ME/CFS.
Check our Facebook each Wednesday, search #OMFScienceWednesday, and visit our website.
#OMFScienceWednesday
Facebook
Twitter
WhatsApp
Email

Latest News

Text across top of image reads: "Experts in infection associated chronic illness" with "WE WANT YOU!" bolded below it. Hand with finger pointed out at viewer. "Apply now" buttons to the left and right with mouse cursor clicking on them.

Infection-associated chronic disease experts needed at ARPA-H

Congress launched ARPA-H (the Advanced Research Projects Agency for Health) this past March to focus on high-risk, high-reward research projects with the goal to solve intractable health problems. As ARPA-H is in the process of hiring its first cohort of program managers, #MEAction and a coalition of chronic disease advocacy groups have published an open

Read More »

BOLD ACTION is a Commitment to Healthcare Justice for People with ME

BOLD ACTION to me, means mobilizing our community to publicly demonstrate our deep and intense—as opposed to shallow and passive—commitment to seeing healthcare justice for people with ME. It is about bringing our issues to the forefront of public consciousness and putting strong pressure on our leaders to act. Taking BOLD ACTION is both a

Read More »

Help keep our work going

We rely on donations from people like you to keep fighting for equality for people with ME.

Donate

Get actions alerts and news direct to your inbox

You can choose what you want to be kept up to date on.

Subscribe
Scroll to Top